info:eu-repo/semantics/article
Gram-positive bacteriocins: usage as antimicrobial agents in veterinary medicine
Fecha
2020-07Registro en:
Schofs, Laureano; Sparo, Mónica Delfina; Sanchez Bruni, Sergio Fabian; Gram-positive bacteriocins: usage as antimicrobial agents in veterinary medicine; Springer; Veterinary Research Communications; 7-2020
0165-7380
1573-7446
CONICET Digital
CONICET
Autor
Schofs, Laureano
Sparo, Mónica Delfina
Sanchez Bruni, Sergio Fabian
Resumen
Antimicrobial resistance is a worldwide spread phenomenon that affects both human and veterinary medicine. This issue has led to a “One Health” approach in order to coordinate efforts and set back the development of drug-resistant microbes. In the search for alternatives therapies, bacteriocins or antimicrobial peptides have proven to be effective both in vitro and in vivo for multiples pathogens, even those resistant to many classic antibiotics. Gram-positive bacteriocins have been the most studied to the present. The use of bacteriocins as therapeutically active molecules is limited mainly due to difficulties in production, purification, delivery systems and regulatory approvals. To overcome some of these limitations, biotechnological and nanotechnological approaches are evaluated. Bacteriocins proved to be a good complement for conventional antibiotics therapy. Antimicrobial peptides are nowadays included in the veterinary products such as udder disinfectant for dairy cattle and dermatological medicated wipe for topical use on dogs, cats, and horses. But there are other potential uses to explore in the veterinary field for both companion and production animals.